On July 1, 2021, IVISYS AB ("IVISYS" or the "Company") issued a press release
with information that the Athanase Tech AB ("Athanase") had achieved control of
more than 90 percent of the shares in IVISYS, and also that Athanase intended
to initiate compulsory redemption proceedings to acquire the remaining shares
in the Company. The press release also stated that IVISYS, at the request of
Athanase, had decided to apply for delisting of its shares from Nasdaq First
North Growth Market. Nasdaq Stockholm AB has also received such an application
from the Company.
The rules of Nasdaq First North Growth Market state that an issuer may be given
observation status if the issuer has applied to have its financial instruments
removed from trading.
With reference to the above, Nasdaq Stockholm AB decides that the shares in
IVISYS AB (IVISYS, ISIN code SE0006800439, order book ID 108037) shall be given
observation status.
For further information concerning this exchange notice please contact Issuer
Surveillance, telephone +46 8 405 70 50.
Nasdaq Stockholm AB© 2021 GlobeNewswire
